Makes plasma derivative products for healthcare providers.
Dec 2024Revenue €7.21B/yrExpenses €6.02B/yr
No trend
Figures by year
Is Grifols profitable?
Yes. In the 12 months to Dec 2024, revenue was €7.21B and expenses €6.02B.
| Fiscal year to | Revenue | Expenses | Operating profit |
|---|---|---|---|
| Dec 2024 | €7.21B | €6.02B | €1.19B |
| Dec 2023 | €6.59B | €5.81B | €782M |
| Dec 2022 | €6.06B | €5.28B | €782M |
| Dec 2021 | €4.93B | €4.34B | €595M |
| Dec 2020 | €5.34B | €4.34B | €996M |
| Dec 2019 | €5.10B | €3.97B | €1.13B |
| Dec 2018 | €4.49B | €3.49B | €994M |
| Dec 2017 | €4.32B | €3.31B | €1.00B |
| Dec 2016 | €4.05B | €3.11B | €939M |
| Dec 2015 | €3.93B | €2.96B | €970M |
When the cash runs out, on the chart. A red line at the date the company’s cash would run out at its latest burn, so you can see whether it gets to break-even first. Part of a subscription.